[1]Wei H, Gu Q. SOX4 promotes high-glucose-induced inflammation and angiogenesis of retinal endothelial cells by activating NF-κB signaling pathway [J]. Open Life Sci, 2022, 17(1): 393-400.
[2]Khademi F, Mohammadi M, Kiani A, et al. Efficient conjugation of aflatoxin M1 with bovine serum albumin through aflatoxin M1-(O-carboxymethyl) oxime and production of anti-aflatoxin M1 antibodies [J]. Jundishapur J Microbiol, 2015, 8(4): e16850.
[3]Xue C, Zhou C, Yang B, et al. Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial[J]. BMJ Open, 2017, 7(2):1-8.
[4]Li ZG, Liu YQ, Zhang HJ, et al. Effect of fosinopril on the renal cortex protein expression profle of otsuka long-evans tokushima fatty rats [J]. Exp Ther Med, 2020, 19(1): 172-182.
[5]Lin Y, Cui Y, Yuan Y, et al. Plasma fibroblast growth factor 23 as a predictor for fosinopril therapeutic efficacy in pediatric primary hypertension[J]. J Am Heart Assoc, 2022, 11(7): e023182.
[6]Zhu XCh, Li XL, Ma WF, et al. Effects of fosinopril on central retinal artery hemodynamics in diabetic patients[J]. Clinical Medicine of China, 2001, 17(7): 532-533. (in Chinese)
朱显成, 李秀兰, 马文璠, 等. 福辛普利对糖尿病患者视网膜中央动脉血流动力学的影响[J]. 中国综合临床, 2001, 17(7): 532-533.
[7]Ni J, Yang F, Huang XR, et al. Dual deficiency of angiotensin-converting enzyme-2 and Mas receptor enhances angiotensin Ⅱ-induced hypertension and hypertensive nephropathy[J]. J Cell Mol Med, 2020, 24(22): 13093-13103.
[8]Liu N, Cai KL. The protective effect of ACE2-Ang-(1-7)Mas axis on diabetic retinopathy[J]. Chinese Journal of Ophthalmologic Medicine, 2013, 2(3): 34-37.(in Chinese)
刘娜, 蔡可丽. ACE2-Ang-(1-7)-Mas轴对糖尿病视网膜病变的保护作用[J]. 中华眼科医学杂志, 2013, 2(3): 34-37.
[9]Dong ZhJ, Tao XY, Wang HB, et al. Effects of purendan superfine powder on expression of retinal vascular endothelial growth factor and pigment epithelium-derived factor in diabetic rats [J]. Acta Anatomic Sinica, 2011, 42(4): 498-502.(in Chinese)
董志军,陶相宜,王海彬,等.菩人丹超微粉对糖尿病大鼠视网膜血管内皮生长因子和色素上皮衍生因子表达的影响[J]. 解剖学报, 2011, 42(4): 498-502.
[10]Hu Y, Xie A, Cheng Q. Upregulated CD200 in pre-retinal proliferative fibrovascular membranes of proliferative diabetic retinopathy patients and its correlation with vascular endothelial growth factor[J]. Inflamm Res, 2019, 68(12): 1071-1079.
[11]Arrigo A, Aragona E, Bandello F. VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy[J]. Ann Med, 2022, 54(1): 1089-1111.
[12]Kuang JS, Zhao YR, Zhao YY, et al. The studying of fosinopril combined with fenofibrate on the preventing of diabetic retinopathy in diabetic mice[J]. Tianjin Medical Journal, 2016, 44 (3): 322-326. (in Chinese)
旷劲松, 赵玉蓉, 赵玉岩, 等. 福辛普利联合非诺贝特对糖尿病小鼠视网膜病变干预作用的研究[J]. 天津医药, 2016, 44(3): 322-326.
[13]Zheng Z, Chen H, Xu X, et al. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy[J]. Exp Eye Res, 2007, 84(4): 745-752.
[14]Chen F, Xiong H, Wang J, et al. Anti-diabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats[J]. J Ethnopharmacol, 2013, 149(3): 729-736.
[15]Oh JH, Kim SW, Kwon SS, et al. The change of macular thickness following single-session pattern scan laser panreti-nal photocoagulation for diabetic retinopathy[J]. Graefes Arch Clin Exp Ophthalmo, 2015, 253(1): 57-63.
[16]Huang H, Hu L, Lin J, et al. Effect of fosinopril on chemerin and VEGF expression in diabetic nephropathy rats [J]. Int J Clin Exp Pathol, 2015, 8(9): 11470-11474.
[17]Sun P, Xu N, Li Y, et al. Destruction of the blood-retina barrier in diabetic retinopathy depends on angiotensin-converting enzyme-mediated TGF-β1/Smad signaling pathway activation[J]. Int Immunopharmacol, 2020, 85(7): 106686.
[18]Park K, Chen Y, Hu Y, et al. Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage [J]. Diabetes, 2009, 58(8): 1902-1913.
[19]Brownlee M. The pathobiology of diabetic complications: a unifying mechanism[J]. Diabetes, 2005, 54(6): 1615-1625.
[20]Guo ShP, Huang ShH, Dong Y, et al. The Amelioration of qingxiangzi (celosia argentea L) extract (CAE) on streptozotocin (STZ)-induced DR and its engaged mechanism[J]. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 2016, 22(18): 27-30. (in Chinese)
郭树鹏, 黄世红, 董彦, 等. 青葙子提取物改善糖尿病视网膜病活性及其机理研究[J]. 中医药导报, 2016, 22(18): 27-30.
[21]Souza SRA, Oliveira SW, Alzamora AC, et al. The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)[J]. Physiol Rev, 2018, 98(1): 505-553.
[22]Foureaux G, Nogueira BS, Coutinho DC, et al. Activation of endogenous angiotensin converting enzyme 2 prevents early injuries induced by hyperglycemia in rat retina[J].Braz J Med Biol Res, 2015, 48(12): 1109-1114.
[23]Dominguez JM, Hu P, Caballero S, et al. Adeno-associated virus overexpression of angiotensin-converting enzyme-2 reverses diabetic retinopathy in type 1 diabetes in mice[J]. Am J Pathol, 2016, 186(6): 1688-1700.
[24]Duan Y, Beli E, Calzi SL, et al. Loss of angiotensin‐converting enzyme 2 exacerbates diabetic retinopathy by promoting bone marrow dysfunction[J]. Stem Cells, 2018, 36(9): 1430-1440.
|